文献速递冠心病心力衰竭与心肌病

循环酮体水平与ST段抬高型心肌梗死后的功能结局相关

Association of Circulating Ketone Bodies With Functional Outcomes After ST-Segment Elevation Myocardial Infarction.
PubMed 文献 · J Am Coll Cardiol · 2021-01-01

该研究基于GIPS-III随机试验的369例STEMI患者,采用核磁共振波谱法在就诊时、24小时和4个月时测量循环酮体水平。结果发现,24小时时酮体水平升高与4个月时心肌梗死面积增大和左室射血分数降低独立相关。

要点

  • STEMI患者急性期循环酮体水平显著升高。
  • 再灌注后24小时酮体水平高与较大心梗面积独立相关。
  • 24小时酮体水平高与较低左室射血分数独立相关。

核心结论

  • STEMI患者循环酮体水平升高,且24小时时酮体水平较高与功能结局不良独立相关,提示酮体代谢在心肌缺血反应中可能发挥作用。

研究设计与样本

  • 研究为来自GIPS-III随机对照试验的369例STEMI患者的纵向分析。
  • 在就诊时、24小时和4个月时采用核磁共振波谱法测量非空腹血浆β-羟丁酸、乙酰乙酸和丙酮的浓度。
  • 4个月时通过心脏磁共振成像测定心肌梗死面积和左室射血分数,采用多变量线性回归分析酮体与结局的关联。

主要发现

  • 就诊时STEMI患者总酮体中位水平为520 μmol/L(IQR:315-997 μmol/L)。
  • 24小时时总酮体水平(206 μmol/L,IQR:174-246)仍高于4个月随访时(166 μmol/L,IQR:143-201),P < 0.001。
  • 24小时总酮体每升高100 μmol/L,心肌梗死面积增大(β = 1.56;95%CI:0.29-2.83;P = 0.016),左室射血分数降低(β = -1.78;95%CI:-3.17至-0.39;P = 0.012)。

临床怎么用

  • 在STEMI患者中,再灌注后24小时酮体水平可作为功能结局的潜在生物标志物。
  • 需进一步研究明确酮体代谢是否可作为治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Circulating ketone bodies (KBs) are increased in patients with heart failure (HF), corresponding with increased cardiac KB metabolism and HF severity. However, the role of circulating KBs in ischemia/reperfusion remains unknown. OBJECTIVES: This study sought to investigate longitudinal changes of KBs and their associations with functional outcomes in patients presenting with ST-segment elevation myocardial infarction (STEMI). METHODS: KBs were measured in 369 participants from a randomized trial on early metformin therapy after STEMI. Nonfasting plasma concentrations of KBs (β-hydroxybutyrate, acetoacetate, and acetone) were measured by nuclear magnetic resonance spectroscopy at presentation, at 24 hours, and after 4 months. Myocardial infarct size and left ventricular ejection fraction (LVEF) were determined by cardiac magnetic resonance imaging at 4 months. Associations of circulating KBs with infarct size and LVEF were determined using multivariable linear regression analyses. RESULTS: Circulating KBs were high at presentation with STEMI (median total KBs: 520 μmol/L; interquartile range [IQR]: 315-997 μmol/L). At 24 hours after reperfusion, KBs were still high compared with levels at 4-month follow-up (206 μmol/L [IQR: 174-246] vs 166 μmol/L [IQR: 143-201], respectively; P < 0.001). Increased KB concentrations at 24 hours were independently associated with larger myocardial infarct size (total KBs, per 100 μmol/L: β = 1.56; 95% confidence interval: 0.29-2.83; P = 0.016) and lower LVEF (β = -1.78; 95% CI: (-3.17 to -0.39; P = 0.012). CONCLUSIONS: Circulating KBs are increased in patients presenting with STEMI. Higher KBs at 24 hours are associated with functional outcomes after STEMI, which suggests a potential role for ketone metabolism in response to myocardial ischemia. (Metabolic Modulation With Metformin to Reduce Heart Failure After Acute Myocardial Infarction: Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III): a Randomized Controlled Trial; NCT01217307).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. de Koning MLY, Westenbrink BD, Assa S, et al. Association of Circulating Ketone Bodies With Functional Outcomes After ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2021. PMID: 34593124. doi:10.1016/j.jacc.2021.07.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。